Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2024 Feb;113(2):195-204.
doi: 10.1007/s00392-023-02217-0. Epub 2023 May 26.

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

Affiliations
Review

GOLD COPD DOCUMENT 2023: a brief update for practicing cardiologists

Alvar Agusti et al. Clin Res Cardiol. 2024 Feb.

Abstract

Many patients seen by cardiologists suffer chronic obstructive pulmonary disease (COPD) in addition to their primary cardiovascular problem. Yet, quite often COPD has not been diagnosed and, consequently, patients have not been treated of their pulmonary disease. Recognizing and treating COPD in patients with CVDs is important because optimal treatment of the COPD carries important benefits on cardiovascular outcomes. The Global Initiative for Chronic Obstructive Lung Disease (GOLD) publishes an annual report that serves as a clinical guideline for the diagnosis and management of COPD around the world and has very recently released the 2023 annual report. Here, we provide a summary of the GOLD 2023 recommendations that highlights those aspects of more interest for practicing cardiologists dealing with patients with CVD who may suffer COPD.

Keywords: Chronic bronchitis; Emphysema; GOLD; Smoking; Tobacco.

PubMed Disclaimer

Conflict of interest statement

Except MB amd AGA, the rest of coauthors are member of the Scientific Committee of GOLD (www.goldcopd.org). No coauthors has any specific conflict of interest to declare in relation to this manuscript.

Figures

Fig. 1
Fig. 1
Diagnosis, assessment of the severity of airflow obstruction, and proposed ABE clinical assessment tool for COPD patients. Reproduced with permission from Ref. [2]
Fig. 2
Fig. 2
Recommended initial pharmacological treatment of COPD patients. To assess the level of symptoms, two simple and validated questionnaires are recommended: the modified Medical Research Council dyspnea scale (mMRC) with one question [67] or the COPD Assessment Test™ (CAT) with eight questions [68]. Abbreviations: eos: blood eosinophil count in cells per microliter. Reproduced with permission from Ref. [2]
Fig. 3
Fig. 3
Proposed clinical strategy for a patient with respiratory symptoms seen by a cardiologist not explained by heart disease. For further explanations, see text

References

    1. Soriano JB, Rigo F, Guerrero D, Yanez A, Forteza JF, Frontera G, et al. High prevalence of undiagnosed airflow limitation in patients with cardiovascular disease. Chest. 2009;137(2):333–340. - PubMed
    1. Global Initiative for Chronic Obstructive Lung Disease (GOLD) 2023. https://goldcopd.org/2023-gold-report-2/
    1. Stolz D, Mkorombindo T, Schumann DM, Agusti A, Ash SY, Bafadhel M, et al. Towards the elimination of chronic obstructive pulmonary disease: a Lancet Commission. Lancet. 2022;400(10356):921–972. - PMC - PubMed
    1. Celli B, Fabbri L, Criner G, Martinez FJ, Mannino D, Vogelmeier C, et al. Definition and nomenclature of chronic obstructive pulmonary disease: time for its revision. Am J Respir Crit Care Med. 2022;206(11):1317–1325. - PMC - PubMed
    1. Celli BR, Fabbri LM, Aaron SD, Agusti A, Brook R, Criner GJ, et al. An updated definition and severity classification of COPD exacerbations: the Rome proposal. Am J Respir Crit Care Med. 2021;204(11):1251–1258. - PubMed

MeSH terms